Barriers and facilitators to medication adherence: a qualitative study with general practitioners

Background General practitioners (GPs) manage the drug therapies of people with chronic diseases, and poor adherence to medication remains a major challenge.Objective This qualitative study examined GPs’ insights into non-adherence and ways of overcoming this problem.Methods We ran four focus groups...

Full description

Saved in:
Bibliographic Details
Main Authors: Marja Airaksinen, Kirsi Kvarnström, Helena Liira
Format: Article
Language:English
Published: BMJ Publishing Group 2018-01-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/8/1/e015332.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823865236447297536
author Marja Airaksinen
Kirsi Kvarnström
Helena Liira
author_facet Marja Airaksinen
Kirsi Kvarnström
Helena Liira
author_sort Marja Airaksinen
collection DOAJ
description Background General practitioners (GPs) manage the drug therapies of people with chronic diseases, and poor adherence to medication remains a major challenge.Objective This qualitative study examined GPs’ insights into non-adherence and ways of overcoming this problem.Methods We ran four focus groups comprising 16 GPs at the Kirkkonummi Health Centre (Southern Finland). Interviews were audiotaped, transcribed verbatim and analysed by inductive content analysis.Main results The two main themes in the discussions with the GPs were non-adherence in the care of chronic disease and increased need for medicine information. The medication management challenges identified were related to: patient-specific factors, the healthcare system, characteristics of drug therapies and the function and role of healthcare professionals as a team. To improve the situation, the GPs offered a number of solutions: improved coordination of care, better patient education and IT systems as well as enhanced interprofessional involvement in the follow-up of patients.Discussion and conclusions With an ageing population, the GPs were increasingly confronted with non-adherence in the care of chronic diseases. They had mostly a positive attitude towards organising care in a more interprofessional manner. To support medication adherence and self-management, the GPs appreciated pharmacists’ assistance especially with patients with polypharmacy and chronic diseases.
format Article
id doaj-art-61cd6c617a504867b97d6ee139c4d819
institution Kabale University
issn 2044-6055
language English
publishDate 2018-01-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-61cd6c617a504867b97d6ee139c4d8192025-02-08T08:55:09ZengBMJ Publishing GroupBMJ Open2044-60552018-01-018110.1136/bmjopen-2016-015332Barriers and facilitators to medication adherence: a qualitative study with general practitionersMarja Airaksinen0Kirsi Kvarnström1Helena Liira2Faculty of Pharmacy, Division of Pharmacology and Pharmacotherapy, Clinical Pharmacy Group, University of Helsinki, Helsinki, Uusimaa, FinlandFaculty of Pharmacy, Division of Pharmacology and Pharmacotherapy, Clinical Pharmacy Group, University of Helsinki, Helsinki, Uusimaa, FinlandOutpatient Clinic for Long-Term Effects of COVID-19, Helsinki University Central Hospital, Helsinki, FinlandBackground General practitioners (GPs) manage the drug therapies of people with chronic diseases, and poor adherence to medication remains a major challenge.Objective This qualitative study examined GPs’ insights into non-adherence and ways of overcoming this problem.Methods We ran four focus groups comprising 16 GPs at the Kirkkonummi Health Centre (Southern Finland). Interviews were audiotaped, transcribed verbatim and analysed by inductive content analysis.Main results The two main themes in the discussions with the GPs were non-adherence in the care of chronic disease and increased need for medicine information. The medication management challenges identified were related to: patient-specific factors, the healthcare system, characteristics of drug therapies and the function and role of healthcare professionals as a team. To improve the situation, the GPs offered a number of solutions: improved coordination of care, better patient education and IT systems as well as enhanced interprofessional involvement in the follow-up of patients.Discussion and conclusions With an ageing population, the GPs were increasingly confronted with non-adherence in the care of chronic diseases. They had mostly a positive attitude towards organising care in a more interprofessional manner. To support medication adherence and self-management, the GPs appreciated pharmacists’ assistance especially with patients with polypharmacy and chronic diseases.https://bmjopen.bmj.com/content/8/1/e015332.full
spellingShingle Marja Airaksinen
Kirsi Kvarnström
Helena Liira
Barriers and facilitators to medication adherence: a qualitative study with general practitioners
BMJ Open
title Barriers and facilitators to medication adherence: a qualitative study with general practitioners
title_full Barriers and facilitators to medication adherence: a qualitative study with general practitioners
title_fullStr Barriers and facilitators to medication adherence: a qualitative study with general practitioners
title_full_unstemmed Barriers and facilitators to medication adherence: a qualitative study with general practitioners
title_short Barriers and facilitators to medication adherence: a qualitative study with general practitioners
title_sort barriers and facilitators to medication adherence a qualitative study with general practitioners
url https://bmjopen.bmj.com/content/8/1/e015332.full
work_keys_str_mv AT marjaairaksinen barriersandfacilitatorstomedicationadherenceaqualitativestudywithgeneralpractitioners
AT kirsikvarnstrom barriersandfacilitatorstomedicationadherenceaqualitativestudywithgeneralpractitioners
AT helenaliira barriersandfacilitatorstomedicationadherenceaqualitativestudywithgeneralpractitioners